PAR paradigm biopharmaceuticals limited..

An IL-8 Investigation, page-5

  1. 4,893 Posts.
    lightbulb Created with Sketch. 7607
    Hi Hamman,


    No is the short answer.

    Certainly another inflammatory condition that iPPS could potentially address.

    Inflammatory Bowel Disease (IBD) is the overarching condition under which diseases such as Chron's disease falls. There is definitely some real chance that iPPS can address Chron's disease which I've come across in the past thus by extrapolation, IBD being another inflammatory condition also should be a possible future indication for us.





 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
44.0¢
Change
0.010(2.33%)
Mkt cap ! $176.8M
Open High Low Value Volume
45.0¢ 45.0¢ 43.0¢ $154.7K 351.0K

Buyers (Bids)

No. Vol. Price($)
5 163826 44.0¢
 

Sellers (Offers)

Price($) Vol. No.
44.5¢ 5253 2
View Market Depth
Last trade - 12.12pm 08/07/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.